He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025
The inspection has concluded with four observations
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
The company received one observation in the Form-483
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
OneSource operates five cGMP facilities and has a strong track record, with 138 successful regulatory and customer audits to date by all major regulatory bodies
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
Subscribe To Our Newsletter & Stay Updated
